Ullman Medical

Company Overview

Snapshot

Founded in January 2009, Ullman Medical operated with 1–10 employees. The company ceased operations in March 2019.

Business overview

Ullman Medical is a Health Tech & Life Sciences company focused on developing a novel botanical extract for treating psoriasis. The company's core technology involves a plant-based compound that has demonstrated positive human clinical data for topical psoriasis treatment. Additionally, preclinical evidence suggests anti-angiogenesis properties that may be effective in treating eye diseases, arthritis, and certain cancers. Ullman Medical aimed to commercialize this compound for psoriasis and develop a therapeutic platform for various immune-deficient diseases, addressing the need for safe and effective topical treatments for chronic skin conditions.

Company Intelligence Q&A

What is Ullman Medical's primary focus?

Ullman Medical focuses on developing a plant-based therapy for psoriasis, with potential applications for other immune-deficient diseases, eye conditions, arthritis, and certain cancers.

When was Ullman Medical founded?

Ullman Medical was founded in January 2009.

What is the current status of Ullman Medical?

Ullman Medical ceased to operate in March 2019.

What was the company's product development stage?

Ullman Medical's product was in the Clinical Trial stage, demonstrating positive human clinical data for topical psoriasis treatment.

What intellectual property has Ullman Medical pursued?

In January 2018, Ullman Medical Inc. pursued patents related to its developments.